Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial.
Tominaga T, Toi M, Abe O, Ohashi Y, Uchino J, Hayasaka H, Abe R, Izuo M, Enomoto K, Watanabe H, Yoshida M, Taguchi T, Koyama H, Senoo T, Toge T, Monden Y, Hattori T, Nomura Y, Sugimachi K, Hirata K, Nakazato H, Miura S, Morimoto T, Asaishi K, Kimijima I, Ota J, Sonoo H, Yamaguchi S; 5'-BC Study Group (5'-DFUR Adjuvant Chemotherapy for Breast Cancer Study Group). Tominaga T, et al. Among authors: sonoo h. Int J Oncol. 2002 Mar;20(3):517-25. Int J Oncol. 2002. PMID: 11836563 Clinical Trial.
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
Tominaga T, Koyama H, Toge T, Miura S, Sugimachi K, Yamaguchi S, Hirata K, Monden Y, Nomura Y, Toi M, Kimijima I, Noguchi S, Sonoo H, Asaishi K, Ikeda T, Morimoto T, Ota J, Ohashi Y, Abe O. Tominaga T, et al. Among authors: sonoo h. J Clin Oncol. 2003 Mar 15;21(6):991-8. doi: 10.1200/JCO.2003.06.014. J Clin Oncol. 2003. PMID: 12637462 Clinical Trial.
Prognostic value of hormone receptors in breast cancer.
Morimoto T, Komaki K, Yamamoto H, Yamakawa T, Tanaka T, Sonoo H, Monden Y. Morimoto T, et al. Among authors: sonoo h. J Surg Oncol. 1988 Oct;39(2):101-7. doi: 10.1002/jso.2930390207. J Surg Oncol. 1988. PMID: 3172790
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer].
Tabei T, Ogita M, Hirata K, Satomi S, Kimura M, Abe R, Morishita Y, Kimura M, Andou J, Higashi Y, Yoshino K, Tominaga K, Kajiwara T, Kitajima M, Koyanagi Y, Watanabe T, Yamaguchi S, Watanabe M, Toyama K, Kanda K, Kashiki Y, Miura S, Kobayashi Z, Aoyama H, Miyazaki I, Oka T, Koyama H, Kinoshita H, Monden M, Takai S, Yayoi E, Kobayashi T, Takatsuka Y, Kajiwara T, Sonoo H, Toge T, Takashima S, Nomura Y, Nagao K, Fujita Y. Tabei T, et al. Among authors: sonoo h. Gan To Kagaku Ryoho. 2002 Jul;29(7):1199-209. Gan To Kagaku Ryoho. 2002. PMID: 12146001 Clinical Trial. Japanese.
[Evaluation of safety and efficacy for bi-weekly Docetaxel and 5'-DFUR combination therapy in patients with advanced or recurrent breast cancer--Phase I study].
Chugoku-Shikoku Breast Cancer Chemotherapy Study Group; Ikeda M, Sonoo H, Tanaka K, Kurebayashi J, Morimoto T, Tangoku A, Komaki K, Kataoka T, Ishiguro K, Yoshizawa K. Chugoku-Shikoku Breast Cancer Chemotherapy Study Group, et al. Among authors: sonoo h. Gan To Kagaku Ryoho. 2006 Jun;33(6):767-71. Gan To Kagaku Ryoho. 2006. PMID: 16770094 Clinical Trial. Japanese.
134 results